Improved Insulin Sensitivity Tirzepatide enhances insulin sensitivity, which means that the cells in the body are more sensitive to the actions of insulin
Anesthesiologists across the US have required patients on GLP-1 agonist to stop it, at least one week before anesthesia
Wegovy pens come pre-filled at five dose levels: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
For parameters without a 95% CI, a range of 25% around the base-case value was used
When administered subcutaneously once weekly, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying
How to take it When it first launched, reaching this dose meant using three 2.4mg pens at the same time